StockData
Amgen Inc logo

Amgen Inc

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$465.45−0.56 (-0.12%)

Close on Nov 2, 2026Market cap $251.64BP/E 28.9Yield 2.08%

Amgen Total Product Sales by Quarter

Total Product Sales — Worldwide volume growth YoY (%) (%)

QuarterlyAnnual

Amgen Total Product Sales: 9.0% in Q1 2026, down 5.0 pts from a year earlier. That is the lowest of the 11 quarters on record here.

Latest, Q1 2026
9.0%
Period ended Mar 31, 2026
Change on a year earlier
-5.0 pts
14.0% in Q1 2025
History
11 quarters
Since Q1 2020
Sources
11
Documents cited below

Where the Q1 2026 figure comes from

“Total product sales increased 4% for the three months ended March 31, 2026, driven by volume growth of 9%, partially offset by declines in net selling price of 2% and 2% from lower wholesaler and end user inventory.”

Source: Form 10-Q (amgn-20260331.htm, filed 2026-05-01) ↗

Reported in Form 8-K Key Results & Form 10-Q / 10-K MD&A.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal Product Sales — Worldwide volume growth YoY (%) (%)Year on yearSource
Q1 2026Mar 31, 20269.0%-5.0 ptsForm 10-Q (amgn-20260331.htm, filed 2026-05-01) ↗
Q1 2025Mar 31, 202514.0%-11.0 ptsForm 10-Q (amgn-20250331.htm, filed 2025-05-02) ↗
Q4 2024Dec 31, 202415.0%-8.0 ptsForm 8-K (amgn-20241231earningsrelea.htm, filed 2025-02-04) ↗
Q3 2024Sep 30, 202412.0%–Form 8-K (amgn-20240930earningsrelea.htm, filed 2024-10-30) ↗
Q2 2024Jun 30, 202410.0%–Form 8-K (amgn-20240630earningsrelea.htm, filed 2024-08-06) ↗
Q1 2024Mar 31, 202425.0%–Form 8-K (amgn-20240331earningsrelea.htm, filed 2024-05-02) ↗
Q4 2023Dec 31, 202323.0%–Form 8-K (amgn-20231231earningsrelea.htm, filed 2024-02-06) ↗
Q4 2020Dec 31, 202013.0%–Form 8-K (amgn-20201231xq4ex991.htm, filed 2021-02-02) ↗
Q3 2020Sep 30, 202018.0%–Form 8-K (amgn-2020930xq3ex991.htm, filed 2020-10-28) ↗
Q2 2020Jun 30, 202013.0%–Form 8-K (amgn-2020630xq1ex991.htm, filed 2020-07-28) ↗
Q1 2020Mar 31, 202015.0%–Form 8-K (amgn-2020331xq1ex991.htm, filed 2020-04-30) ↗

Cite this data

StockData. (2026). Amgen Total Product Sales (%), quarterly Q1 2020–Q1 2026 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/prod-total-vol

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.